The Advisory Committee on Immunization Practices' April meeting was crowded with topics including both pentavalent and quadrivalent meningococcal offerings. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
